UnknownEarly Phase 1

Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection

China60 participantsStarted 2020-10-17

Plain-language summary

The study aims to assess the antibacterial effect and symptoms-relief of Qingfei Granule in the patients with pediatric acute upper respiratory tract infection with bacterial infection.

Who can participate

Age range5 Years – 14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis with the acute upper respiratory tract infection;
✓. Diagnosis with wind-heat Zheng according to Chinese medicine;
✓. Age: 5-14 years old;
✓. Body temperature ≥ 37.5 ℃;
✓. White blood cell count\> 12 × 10\^9 / L, and / or neutrophil ratio over than 70%;
✓. The informed consent process complies with the regulations, and the legal agent or the child (≥8 years old) jointly sign the informed consent

What they're measuring

Bacterial clearance

Timeframe: 0, Day 5

Trial details

NCT IDNCT04479657

SponsorZhong Wang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12

Contact for this trial

Jun Liu

8610-64093207 franlj1104@aliyun.com

View on ClinicalTrials.gov More Upper Respiratory Tract Infection trials